A rare case of hyporeninemic hypertension: Answers.
作者信息
Mashmoushi Ahmad, Choudhary Abha, Thomas Christie P, Wolf Matthias T F
机构信息
Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pediatric Endocrinology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
出版信息
Pediatr Nephrol. 2021 Mar;36(3):569-573. doi: 10.1007/s00467-020-04667-4. Epub 2020 Jun 30.
Abstract
摘要
相似文献
1
A rare case of hyporeninemic hypertension: Answers.一例罕见的低肾素性高血压病例：答案
Pediatr Nephrol. 2021 Mar;36(3):569-573. doi: 10.1007/s00467-020-04667-4. Epub 2020 Jun 30.
2
Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.散发性醛固酮瘤中的新型KCNJ5突变降低了Kir3.4细胞膜丰度。
J Clin Endocrinol Metab. 2015 Jan;100(1):E155-63. doi: 10.1210/jc.2014-3009.
3
KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.KCNJ5 突变可预测醛固酮瘤手术治疗后高血压的缓解情况。
J Hypertens. 2018 Mar;36(3):619-627. doi: 10.1097/HJH.0000000000001578.
4
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.醛固酮生物合成的调节由 Kir3.4（KCNJ5）钾通道。
Clin Exp Pharmacol Physiol. 2013 Dec;40(12):895-901. doi: 10.1111/1440-1681.12151.
5
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.一例由影响关键盐桥Kir3.4残基的新发突变引起的严重醛固酮增多症病例。
J Clin Endocrinol Metab. 2015 Jan;100(1):E114-8. doi: 10.1210/jc.2014-3636.
6
Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.儿童患者伴 KCNJ5 变异的库欣综合征经低剂量酮康唑治疗成功。
J Clin Endocrinol Metab. 2021 May 13;106(6):1606-1616. doi: 10.1210/clinem/dgab118.
7
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.KCNJ5基因的突变决定了原发性醛固酮增多症的表现及治愈可能性。
ANZ J Surg. 2015 Apr;85(4):279-83. doi: 10.1111/ans.12470. Epub 2013 Nov 26.
8
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.KCNJ5基因两个新的种系突变在无原发性醛固酮增多症但有促肾上腺皮质激素依赖性醛固酮分泌过多的高血压患者中的功能特征。
Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132. Epub 2016 Jul 12.
9
Familial hyperaldosteronism type III a novel case and review of literature.家族性醛固酮增多症 III 型：一例新病例及文献复习。
Rev Endocr Metab Disord. 2019 Mar;20(1):27-36. doi: 10.1007/s11154-018-9481-0.
10
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.一个导致家族性醛固酮增多症 III 型的新型 Y152C KCNJ5 突变。
J Clin Endocrinol Metab. 2013 Nov;98(11):E1861-5. doi: 10.1210/jc.2013-2428. Epub 2013 Sep 13.
引用本文的文献
1
A narrative review of Hyporeninemic hypertension-an indicator for monogenic forms of hypertension.低肾素性高血压——单基因形式高血压的一个指标的叙述性综述。
Pediatr Med. 2022 May;5. doi: 10.21037/pm-21-48. Epub 2022 May 28.
本文引用的文献
1
Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.下一代测序的靶向广泛基因检测为肾脏病患者的诊断和治疗提供了信息。
Nephrol Dial Transplant. 2021 Jan 25;36(2):295-305. doi: 10.1093/ndt/gfz173.
2
Primary Aldosteronism.原发性醛固酮增多症
Hypertension. 2019 Sep;74(3):458-466. doi: 10.1161/HYPERTENSIONAHA.119.12935. Epub 2019 Jul 22.
3
Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals.WNK/SPAK 通路对肾脏 NaCl 共转运蛋白的调节：遗传修饰动物模型的启示。
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F146-F158. doi: 10.1152/ajprenal.00288.2018. Epub 2018 Aug 8.
4
CLCN2 chloride channel mutations in familial hyperaldosteronism type II.家族性醛固酮增多症 II 型中 CLCN2 氯离子通道突变。
Nat Genet. 2018 Mar;50(3):349-354. doi: 10.1038/s41588-018-0048-5. Epub 2018 Feb 5.
5
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.钙通道CACNA1H的复发性功能获得性突变导致早发性高血压伴原发性醛固酮增多症。
Elife. 2015 Apr 24;4:e06315. doi: 10.7554/eLife.06315.
6
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.一例由影响关键盐桥Kir3.4残基的新发突变引起的严重醛固酮增多症病例。
J Clin Endocrinol Metab. 2015 Jan;100(1):E114-8. doi: 10.1210/jc.2014-3636.
7
The multifaceted mineralocorticoid receptor.多功能盐皮质激素受体
Compr Physiol. 2014 Jul;4(3):965-94. doi: 10.1002/cphy.c130044.
8
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.醛固酮瘤和原醛症中体细胞和种系 CACNA1D 钙通道突变。
Nat Genet. 2013 Sep;45(9):1050-4. doi: 10.1038/ng.2695. Epub 2013 Aug 4.
9
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.醛固酮生物合成的调节由 Kir3.4（KCNJ5）钾通道。
Clin Exp Pharmacol Physiol. 2013 Dec;40(12):895-901. doi: 10.1111/1440-1681.12151.
10
Role of KCNJ5 in familial and sporadic primary aldosteronism.KCNJ5 在家族性和散发性原发性醛固酮增多症中的作用。
Nat Rev Endocrinol. 2013 Feb;9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11.
Zotero 插件